Eli Lilly partners with Hims & Hers to expand access to obesity drugs, with CEO Andrew Dudum highlighting the benefits of collaboration between the pair
This week's top stories include Pfizer's appointment of Cecile Guegan as CFO, Regeneron's strong Q3 performance and Cancer Research UK's media partnership
Siemens Healthineers CEO Bernd Montag says Siemens will remain part of "our heritage" but is ready to write the "next chapters of our journey"
This week's top stories include Pfizer's appointment of Cecile Guegan as CFO, Regeneron's strong Q3 performance and Cancer Research UK's media partnership
Eli Lilly partners with Hims & Hers to expand access to obesity drugs, with CEO Andrew Dudum highlighting the benefits of collaboration between the pair
AbbVie’s more than £120m (US$161m) investment will harness Oxford’s “leading life sciences ecosystem,” says Global Head of Discovery Research Jon Sedgwick
CEO Albert Bourla describes Pfizer’s Q3 2026 results as demonstrating “strong momentum”, as the firm also appointed Cecile Guegan as permanent CFO
More News
NVIDIA’s David Niewolny says its collaboration with Siemens Healthineers and Varian could help “redefine cancer care” through AI-powered radiotherapy
Sanofi CEO Belén Garijo says the company’s investment in an insulin manufacturing facility in Germany is about “building a stronger, more resilient Europe”
Waters Corporation’s Dave Leitham, Vice President of Informatics, says the “big win for scientists” from AI-enabled, automated lab workflows “is time”
INTERPOL Secretary General Valdecy Urquiza says the agreement with WHO is crucial to security efforts as “crime and health are increasingly interconnected”
IBM’s Kaitlyn Roche and MVP Health Care’s Samantha Demick shared insights on automating healthcare vendor compliance and managing risk in a webinar
FedEx Europe's Toby Hay, Managing Director of International Marketing, explains how its new portal improves shipment visibility and control
Eoghan O’Lionard, CEO of Wates Group, says neighbourhood health centres operated by NHS England could “become part of the infrastructure of a community”
Roche’s $1.06bn obesity care deal could deliver “truly differentiated, next-generation therapy,” says Enza di Modungo, VP of Roche Pharma Partnering
AXA Health has named former Bupa, Allianz Partners and Cigna Healthcare senior medical executive Anne Lepetit as its Chief Medical Officer
Teva’s Weltruza was “developed with the patient in mind from day one,” says Chris Fox, Executive VP, as the company advances its “Pivot to Growth” strategy